Preview: Kairos Pharma, Ltd Set To IPO Tomorrow

Kairos Pharma, Ltd KAPA IPO will take place September, 12 on the NASDAQ exchange under the ticker KAPA.

The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on March 11, 2025.

See also: Benzinga IPO Calendar

About Kairos Pharma, Ltd

Kairos Pharma, Ltd is a clinical-stage biopharmaceutical company advancing therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.